Navigation Links
In The Face Of Increasing Healthcare Spend And High-Cost Targeted Treatment, Market Access Barriers Continue To Rise For Targeted Oncology Drugs

BURLINGTON, Mass., Sept. 25, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite being a therapeutic area with high unmet need and a rich development pipeline, the barriers to market access for oncology therapies continue to rise. According to findings from the Strategic Insights report entitled Market Access Levers and Barriers: Maximizing the Opportunity for Key Oncology Agents, payer influence continues to grow as healthcare systems face escalating costs and diminishing resources to pay. As a therapy area with numerous high-cost targeted therapies, oncology drugs are a key target for controlling and reducing healthcare spend.

The findings also reveal a deep pipeline of agents in development for oncology; Decision Resources forecasts the launch of new targeted oncology drugs by 2019: a mix of small-molecule targeted therapies and targeted biologic agents. Given the depth of the targeted pipeline, and the increasingly cost-constrained environment, demonstrating innovation and proving value will be critical for obtaining favorable market access.

"Therapeutic innovation, improved target specificity and demonstrated downstream value are key market access levers that will encourage payers to think beyond the drug's price tag," said Decision Resources Senior Vice President, Research Kate Hohenberg. "In particular, factors that improve specificity such as personalized medicine, biomarkers and targeted patient populations increase the odds that a targeted therapy will work for a specific patient. And, value is derived from improved clinical effectiveness and later-line cost savings."

About Decision Resources
Decision Resources ( is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at

All company, brand, or product names contained in this document may be trademarks or
registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group
Christopher Comfort

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Internal and External Communications Excellence for the Pharmaceutical Industry: Increasing Organizational Effectiveness
2. Big Pharma and Universities Increasingly Work to Advance Life Science Knowledge by Forming Strategic Partnerships, Public-Private Partnerships, and Open Innovation Programs: Pharmaceutical Research Collaborations Summit
3. Sangui and SastoMed Complement Licensing Agreement in View of Increasing Sales Success
4. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
5. Gastroenterologists Indicate They Are Increasingly Using Biologics to Treat Patients with Crohns Disease in Remission than They Were One Year Ago, According to a Recent BioTrends Report
6. Probiotic Action Shares Insight on What New Foods Are Increasing the Strength of Bad Bacteria
7. Frost & Sullivan Recognizes Sciformixs Continued Growth in the Increasingly Complex Pharmaceutical KPO Market
8. Growing Awareness & Increasing Number of Indications Drive the Global Intravenous Immunoglobulin Market, According to a New Report by Global Industry Analysts, Inc.
9. Report Finds Healthcare Sales Job Openings are Down but Increasing
10. SynteractHCR Increasing Participation in Industry Events in US and Europe
11. Increasing Need for Supply of High-Quality Water Drives Growth in the Water Analysis Instrumentation Market, According to New Report by Global Industry Analysts, Inc.
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Global Stem Cells Group ... of a new closed system for isolating adipose-derived stem cells. The announcement starts a ... of adipose tissue. SVF is a component of the lipoaspirate obtained from liposuction of ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
(Date:11/30/2015)... 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the ... C.W. Wong to its Board of Directors to replace ... with a wealth of experience as co-founder of Resverlogix, with ... --> --> Dr. Wong remarked, ... of directors. Zenith,s long standing expertise in epigenetics and the ...
(Date:11/30/2015)... SAN DIEGO , Nov. 30, 2015 ... today that the company has acquired Cypher Genomics, Inc., ... and robust human genomic interpretation software solutions. The ... who will join HLI including Cypher CEO and Co-founder, ... head of HLI,s Pediatric Business.  Financial details of the ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... 12, 2015  Arxspan has entered into an ... Harvard for use of its ArxLab cloud-based suite ... The partnership will support the institute,s efforts to ... research information internally and with external collaborators. The ... managing the Institute,s electronic laboratory notebook, compound and ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):